PCN65 Cost-Effectiveness Analysis of Hypomethylant Therapy (Decitabine/ Azacitidine) Compared to Transfusion Therapy in Myelodysplastic Syndrome in Colombia
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1182
https://www.valueinhealthjournal.com/article/S1098-3015(12)01247-8/fulltext
Title :
PCN65 Cost-Effectiveness Analysis of Hypomethylant Therapy (Decitabine/ Azacitidine) Compared to Transfusion Therapy in Myelodysplastic Syndrome in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01247-8&doi=10.1016/j.jval.2012.03.1182
First page :
A219
Section Title :
Cancer
Open access? :
No
Section Order :
700